Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with persistent atrial fibrillation (an ongoing irregular heart rhythm condition)
- People whose level of symptoms related to their atrial fibrillation is not yet fully known or measured
Who may not be able to join:
- People who have a blood clot in a specific part of the heart called the left atrial appendage
- People who have previously had a catheter-based or surgical procedure to treat their atrial fibrillation
- People who cannot tolerate, or have medical reasons preventing them from taking, a medication called Amiodarone
- People who have medical reasons preventing them from taking blood-thinning medication
- People who are already taking part in another clinical trial that involves random assignment to a treatment group
- People who are unable or unwilling to give their formal agreement to participate
- People who have a history of not following their prescribed medical treatments
- People who are pregnant (a pregnancy test will be required before enrolment for women who could potentially become pregnant)
- People who are currently breastfeeding
- People for whom the trial doctor believes participation would not be in their best interest
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Birnie, MD, Ottawa Heart Institute Research Corporation
Phone: 613-696-7000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference between AFEQT Scores pre and post cardioversion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.